Thousands of people with an aggressive form of arthritis will be condemned to a life of misery after the health watchdog rejected an appeal to approve a new drug for NHS patients, a charity has said. The National Institute for Health and Clinical Excellence (Nice) has decided that abatacept (Orencia) is not cost effective. The drug is used to treat moderate to severe rheumatoid arthritis.
New arthritis drug rejected over cost - The Telegraph 24th April 2008
Thursday, April 24, 2008
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment